RecruitingNot ApplicableNCT07306065

University of Central Florida Music Study

Scientific Proof of Music Therapy's Impact on Alzheimer's Disease


Sponsor

University of Central Florida

Enrollment

60 participants

Start Date

Aug 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study at the University of Central Florida explores how music affects memory and brain function in older adults, including those with mild cognitive impairment (early memory problems) and those with Alzheimer's disease or dementia. **You may be eligible if...** - You are 50 years or older - You fall into one of three groups: no cognitive impairment, mild cognitive impairment, or Alzheimer's disease/dementia - You (or your legal representative) can read or speak English and agree to follow study procedures - Pregnant women may also choose to participate **You may NOT be eligible if...** - You are 49 years old or younger - You are a prisoner - You are unable to understand English or provide consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMusic intervention

UCF music concert where the participants will listen to symphonic, classical music for 1 hour.


Locations(1)

University of Central Florida

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07306065


Related Trials